Tag: health-state utility

“MAPPING STUDIES” IN COST-UTILITY ANALYSES: NEW RECOMMENDATIONS FROM ISPOR TASK FORCE

Guidance for the Consistent Application of Appropriate Analytical Methods   Princeton, NJ—February 14, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good

Posted in Announcements, ISPOR News & Press, Value in Health Tagged with: , ,

ISPOR TASK FORCE PROVIDES RECOMMENDATIONS ON THE COLLECTION OF HEALTH-STATE UTILITY DATA IN CLINICAL STUDIES

Five Areas of Guidance Enable Optimum Health-State Utility Measurement  Princeton, NJ—October 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Task Force on Good Practices for Outcome Research—Measurement of Health-State Utility Values for Economic Models in Clinical Studies—has published

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: ,

WHAT IS THE IMPACT OF ADDING EXTRA HEALTH DIMENSIONS TO THE EQ-5D?

Oxford, UK  –  Generic preference-based measures of health are commonly used to evaluate the impact of diseases and their treatments on overall health related quality of life by weighting their dimensions using people’s value judgements. However, these measures, including the

Posted in Preference-Based Assessments, Value in Health Tagged with: , , , , , ,

GOOD NEWS FOR SUFFERERS OF CHRONIC AIRWAY DISEASE

Auckland, New Zealand – Chronic obstructive pulmonary disease (COPD), resulting usually from long term tobacco smoking and/or severe air pollution, is a major health issue in most countries, and

Posted in Uncategorized Tagged with: , , ,

Let’s Think for a Minute: Do Respondents Need Time to Deliberate When Undertaking Health State Valuation Exercises?

Perth, Western Australia – Increasingly, economic analyses are being used to make decisions on how to pay for new medicines and health care practices. Measuring and valuing quality of life are key components of economic analysis but, surprisingly, we know little

Posted in Preference-Based Assessments, Value in Health Tagged with: , ,